SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending with high conviction as Dr. PSS's recent presentation on Anktiva's potential to prevent and cure cancer sparks widespread community excitement, fueling intense short squeeze speculation and institutional interest amidst perceived regulatory resistance.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending due to its strategic pivot from Bitcoin mining to a high-performance computing and AI data center provider, backed by significant power infrastructure acquisitions and bullish institutional coverage. The community is actively discussing its high short interest and long-term growth potential as an AI infrastructure play, amidst varying views on short-term price action.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending with notable pre-earnings strength, fueled by expectations of an 18th consecutive beat and raise and the continued integration of its OpenAI partnership into its AI marketing platform. Community sentiment is divided between strong bullish conviction in its proprietary data moat and concerns over broader software sector headwinds potentially leading to a "sell the news" event.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is trending following a significant strategic collaboration with Astellas for its VIR-5500 prostate cancer asset, bolstered by positive Phase 1 trial data and multiple analyst upgrades. The community is actively discussing the substantial financial commitment and the potential for a short squeeze, given the tight float and notable short interest.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk Corp is experiencing high volatility as a recent short report from Citron Research, arguing the cyclicality of NAND, faces strong counter-arguments from the community highlighting persistent memory shortages and surging AI-driven demand. This has spurred intense trading and a sharp divide between those predicting a pullback and others seizing the buying opportunity.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining, now Cipher Digital, is drawing significant attention after its earnings call underscored a successful pivot to AI/HPC data centers, showcasing on-schedule builds and an expanding pipeline of hyperscaler deals, which overshadows its Q4 financial miss. The community is actively discussing the strategic re-rating potential, driven by confirmed multi-billion dollar contracts and anticipation of new "imminent" agreements.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

Rich Sparkle Holdings Limited (ANPA) is trending due to its acquisition of TikTok icon Khaby Lame's core company, sparking community excitement about potential explosive growth in digital content. However, the move is also drawing significant skepticism and warnings of a pump-and-dump, with many questioning its valuation compared to fundamentals.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday (WDAY) is trending after its latest earnings release, which, despite beating estimates, triggered a significant aftermarket sell-off amidst concerns about future subscription growth and mixed reactions to its AI acquisition strategy and recent leadership changes. The community is sharply divided, with bulls viewing the dip as a buying opportunity while bears contend that AI disruption fundamentally challenges the SaaS business model, anticipating further declines for the enterprise software giant.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as a key director's substantial insider purchase and a new LPGA marketing partnership signal strong long-term confidence, even while the community debates its undervalued status, the impact of increased growth-oriented expenses, and ongoing buyout speculation.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending following a significant $500 million equipment loan from a leading financial institution, perceived by the community as strong institutional backing for its massive 11GW AI energy campus, Project Matador. This pivotal financing has sparked active discussions about an imminent tenant announcement and positions FRMI as a high-volatility, event-driven play in the critical AI infrastructure sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SENS Eversense 365 Integrated With twiist Gains Full Availability

Senseonics rolls out Eversense 365 integrated with Sequel's twiist AID system, aiming to boost CGM adoption with its year-long wear advantage.

Senseonics Holdings, Inc. (NYSE:SENS) Receives Average Rating of "Buy" from Brokerages

Shares of Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) have been assigned a consensus rating of "Buy" from the six ratings firms that are presently covering the stock, MarketBeat Ratings...

All You Need to Know About Senseonics (SENS) Rating Upgrade to Buy

Senseonics (SENS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Senseonics (SENS) Moves 5.3% Higher: Will This Strength Last?

Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval

Senseonics stock jumps after Eversense 365 wins CE Mark, expanding Europe access for its one-year CGM and strengthening the long-term growth outlook.

Senseonics (NYSE:SENS) Stock Price Up 3.9% - Time to Buy?

Senseonics (NYSE:SENS) Shares Up 3.9% - Should You Buy...

SENS Stock Up as Eversense 365 Enters AID Market With twiist System

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.

<ul class="summary-bullets"><li>Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.&nbsp;</li><li>Combining twiist with Senseonics’s Eversense 365 marks the first time when a one-year CGM system has been integrated with an AID, the company said.</li><li>The commercial launch of the integrated products provides people with type 1 diabetes a new level of flexibility and personalization in their diabetes management.</li></ul>Shares of Senseonics Holdings, Inc. (SENS) closed over 8% higher on Thursday after the company announced the first commercial usage of its year-long implantable Eversense 365 Continuous Glucose Monitor (CGM) with Sequel MedTech’s Automated Insulin Delivery (AID) system.Senseonics said that alongside Sequel, it has launched the integration of the products with the first patients having received a Sequel twiist AID system paired with the Eversense 365 CGM.Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.The company’s shares were up 0.14% in after-market hours at the time of writing.<h2 class="st-heading-2">World’s First AID Integration</h2>Combining twiist with Senseonics’s Eversense 365 marks the first time when a one-year CGM system has been integrated with an AID, representing a major milestone in long-term diabetes management by reducing the need for regular sensor changes and re-pairing, while maintaining exceptional accuracy, the company said.“Patients and providers want reliable, long-term automated glucose readings and we’ve taken a major step forward in simplifying and personalizing diabetes management by integrating Eversense 365’s One Year CGM system with the twiist AID system for patients that require insulin,” Goodnow said.Meanwhile, Alan Lotvin, CEO of Sequel MedTech said that diabetes management is deeply personal, and no single approach works for everyone. “Our focus on personalization means Sequel is committed to creating choice for people living with diabetes; integration with the Eversense CGM is an important step in this journey, enabling more people to experience the precision and confidence that twiist AID system brings to diabetes management,” he added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around SENS stock stayed in the ‘bullish’ territory over the past day amid ‘high’ message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_09_at_3_22_54_AM_png_4f2919b8d5.webp" alt="On Stocktwits, retail sentiment around SENS stock stayed in the ‘bullish’ territory over the past day amid ‘high’ message volumes." width="1303" height="157"></figure><a href="https://stocktwits.com/symbol/SENS">Shares of SENS</a> have lost over 17% of their value in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

An Asian teenager with type 1 diabetes uses an at home glucometer to test his blood sugar levels. | Image source: Getty Images

SENS Shares Surge After First Commercial Patients Use AID-Integrated Continuous Glucose Monitor System

Senseonics announced the first commercial usage of its year-long implantable Eversense 365 Continuous Glucose Monitor (CGM) with Sequel MedTech’s Automated Insulin Delivery (AID) system.

Equity

Senseonics Holdings, Inc. (NYSE:SENS) Receives Average Rating of "Buy" from Analysts

Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) has been given an average recommendation of "Buy" by the six analysts that are covering the company, MarketBeat.com reports. One equities...

Maven Securities LTD Takes Position in Senseonics Holdings, Inc. $SENS

Maven Securities LTD acquired a new stake in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and...

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Ahead of earnings, sentiment is split between blowout AI growth and concerns around macro pressure, positioning, and post-ER volatility. How do you see it playing out?

SENS
Senseonics Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SENS News

SENSSenseonics Holdings Inc